1. Cover letter attachments for controlled correspondence and ANDA submissions: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, June 2023 Subject(s): Correspondence as TopicDrug ApprovalDrug IndustryDrugs, GenericGovernment RegulationUnited StatesUnited States. Food and Drug Administration
